Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 502

1.

Communication About Hereditary Cancers on Social Media: A Content Analysis of Tweets About Hereditary Breast and Ovarian Cancer and Lynch Syndrome.

Allen CG, Roberts M, Andersen B, Khoury MJ.

J Cancer Educ. 2018 Dec 3. doi: 10.1007/s13187-018-1451-4. [Epub ahead of print]

PMID:
30506398
2.

Current Social Media Conversations about Genetics and Genomics in Health: A Twitter-Based Analysis.

Allen CG, Andersen B, Khoury MJ, Roberts MC.

Public Health Genomics. 2018 Nov 22:1-7. doi: 10.1159/000494381. [Epub ahead of print]

PMID:
30466105
3.

Training the Twenty-First Century Cancer Epidemiologist.

Lam TK, Lavigne JA, Qadir X, Khoury MJ, Schully SD.

J Cancer Educ. 2018 Sep 24. doi: 10.1007/s13187-018-1426-5. [Epub ahead of print]

PMID:
30251077
4.

HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders.

Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ.

Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1. [Epub ahead of print]

PMID:
30197419
5.

Correction: A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.

Khoury MJ, Feero WG, Chambers DA, Brody LC, Aziz N, Green RC, Janssens ACJW, Murray MF, Rodriguez LL, Rutter JL, Schully SD, Winn DM, Mensah GA.

PLoS Med. 2018 Aug 16;15(8):e1002650. doi: 10.1371/journal.pmed.1002650. eCollection 2018 Aug.

6.

A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.

Khoury MJ, Feero WG, Chambers DA, Brody LC, Aziz N, Green RC, Janssens ACJW, Murray MF, Rodriguez LL, Rutter JL, Schully SD, Winn DM, Mensah GA.

PLoS Med. 2018 Aug 2;15(8):e1002631. doi: 10.1371/journal.pmed.1002631. eCollection 2018 Aug. Erratum in: PLoS Med. 2018 Aug 16;15(8):e1002650.

7.

Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.

Green RF, Ari M, Kolor K, Dotson WD, Bowen S, Habarta N, Rodriguez JL, Richardson LC, Khoury MJ.

Genet Med. 2018 Jun 15. doi: 10.1038/s41436-018-0028-2. [Epub ahead of print] Review.

PMID:
29907802
8.

Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).

Bucholz EM, Rodday AM, Kolor K, Khoury MJ, de Ferranti SD.

Circulation. 2018 May 22;137(21):2218-2230. doi: 10.1161/CIRCULATIONAHA.117.032321. Epub 2018 Mar 26.

PMID:
29581125
9.

Evidence-based medicine and big genomic data.

Ioannidis JPA, Khoury MJ.

Hum Mol Genet. 2018 May 1;27(R1):R2-R7. doi: 10.1093/hmg/ddy065.

10.

Communication of cancer-related genetic and genomic information: A landscape analysis of reviews.

Peterson EB, Chou WS, Gaysynsky A, Krakow M, Elrick A, Khoury MJ, Kaphingst KA.

Transl Behav Med. 2018 Jan 29;8(1):59-70. doi: 10.1093/tbm/ibx063. Review.

PMID:
29385592
11.
12.

From public health genomics to precision public health: a 20-year journey.

Khoury MJ, Bowen MS, Clyne M, Dotson WD, Gwinn ML, Green RF, Kolor K, Rodriguez JL, Wulf A, Yu W.

Genet Med. 2018 Jun;20(6):574-582. doi: 10.1038/gim.2017.211. Epub 2017 Dec 14. Review.

PMID:
29240076
13.

The current state of funded NIH grants in implementation science in genomic medicine: a portfolio analysis.

Roberts MC, Clyne M, Kennedy AE, Chambers DA, Khoury MJ.

Genet Med. 2017 Oct 26. doi: 10.1038/gim.2017.180. [Epub ahead of print]

14.

Human Genome Sequencing at the Population Scale: A Primer on High-Throughput DNA Sequencing and Analysis.

Goldfeder RL, Wall DP, Khoury MJ, Ioannidis JPA, Ashley EA.

Am J Epidemiol. 2017 Oct 15;186(8):1000-1009. doi: 10.1093/aje/kww224. Review.

15.

Editorial: Emergence of Gene-Environment Interaction Analysis in Epidemiologic Research.

Khoury MJ.

Am J Epidemiol. 2017 Oct 1;186(7):751-752. doi: 10.1093/aje/kwx226. No abstract available.

PMID:
28978194
16.

Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014.

Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ.

Genet Med. 2018 Apr;20(4):428-434. doi: 10.1038/gim.2017.118. Epub 2017 Sep 21.

PMID:
28933789
17.

BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.

Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ.

MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.

18.

A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system.

Lu CY, Williams MS, Ginsburg GS, Toh S, Brown JS, Khoury MJ.

Genet Med. 2018 Apr;20(4):390-396. doi: 10.1038/gim.2017.122. Epub 2017 Aug 10. Review.

PMID:
28796238
19.

Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.

Knowles JW, Rader DJ, Khoury MJ.

JAMA. 2017 Jul 25;318(4):381-382. doi: 10.1001/jama.2017.8543. No abstract available.

20.

No Shortcuts on the Long Road to Evidence-Based Genomic Medicine.

Khoury MJ.

JAMA. 2017 Jul 4;318(1):27-28. doi: 10.1001/jama.2017.6315. No abstract available.

21.

Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research.

Phillips KA, Deverka PA, Sox HC, Khoury MJ, Sandy LG, Ginsburg GS, Tunis SR, Orlando LA, Douglas MP.

Genet Med. 2017 Oct;19(10):1081-1091. doi: 10.1038/gim.2017.21. Epub 2017 Apr 13. Review.

22.

Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.

Lynch JA, Berse B, Dotson WD, Khoury MJ, Coomer N, Kautter J.

Genet Med. 2017 Aug;19(8):890-899. doi: 10.1038/gim.2016.209. Epub 2017 Jan 26.

PMID:
28125086
23.

Evaluating Precision Medicine's Ability to Improve Population Health-Reply.

Khoury MJ, Galea S.

JAMA. 2017 Jan 24;317(4):441. doi: 10.1001/jama.2016.20006. No abstract available.

PMID:
28118448
24.

The current state of implementation science in genomic medicine: opportunities for improvement.

Roberts MC, Kennedy AE, Chambers DA, Khoury MJ.

Genet Med. 2017 Aug;19(8):858-863. doi: 10.1038/gim.2016.210. Epub 2017 Jan 12. Review.

PMID:
28079898
25.

Trends in published meta-analyses in cancer research, 2008-2013.

Qadir XV, Clyne M, Lam TK, Khoury MJ, Schully SD.

Cancer Causes Control. 2017 Jan;28(1):5-12. doi: 10.1007/s10552-016-0830-6. Epub 2016 Nov 29.

26.

CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.

Rodriguez JL, Thomas CC, Massetti GM, Duquette D, Avner L, Iskander J, Khoury MJ, Richardson LC.

MMWR Morb Mortal Wkly Rep. 2016 Nov 25;65(46):1291-1294. doi: 10.15585/mmwr.mm6546a3.

27.

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.

Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, Tiro JA, Zauber AG, Winn DM, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1449-1455. Epub 2016 Aug 9.

28.

The need for a next-generation public health response to rare diseases.

Valdez R, Grosse SD, Khoury MJ.

Genet Med. 2016 Oct 27;19(5):489-490. doi: 10.1038/gim.2016.166. Epub 2016 Oct 27. No abstract available.

29.

Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing.

Grosse SD, Khoury MJ.

Genet Med. 2016 Oct;18(10):963-5. doi: 10.1038/gim.2016.121. Epub 2016 Sep 8. No abstract available.

30.

Will Precision Medicine Improve Population Health?

Khoury MJ, Galea S.

JAMA. 2016 Oct 4;316(13):1357-1358. doi: 10.1001/jama.2016.12260. No abstract available.

PMID:
27541310
31.

The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research.

Kennedy AE, Khoury MJ, Ioannidis JP, Brotzman M, Miller A, Lane C, Lai GY, Rogers SD, Harvey C, Elena JW, Seminara D.

Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1392-1401. Epub 2016 Jul 20.

32.

A knowledge base for tracking the impact of genomics on population health.

Yu W, Gwinn M, Dotson WD, Green RF, Clyne M, Wulf A, Bowen S, Kolor K, Khoury MJ.

Genet Med. 2016 Dec;18(12):1312-1314. doi: 10.1038/gim.2016.63. Epub 2016 Jun 9.

33.

Convergence of Implementation Science, Precision Medicine, and the Learning Health Care System: A New Model for Biomedical Research.

Chambers DA, Feero WG, Khoury MJ.

JAMA. 2016 May 10;315(18):1941-2. doi: 10.1001/jama.2016.3867. No abstract available.

34.

Implementation of the 21-gene recurrence score test in the United States in 2011.

Lynch JA, Berse B, Petkov V, Filipski K, Zhou Y, Khoury MJ, Hassett M, Freedman AN.

Genet Med. 2016 Oct;18(10):982-90. doi: 10.1038/gim.2015.218. Epub 2016 Feb 11.

PMID:
26890451
35.

From genomic medicine to precision medicine: highlights of 2015.

Auffray C, Caulfield T, Griffin JL, Khoury MJ, Lupski JR, Schwab M.

Genome Med. 2016 Jan 29;8(1):12. doi: 10.1186/s13073-016-0265-4. No abstract available.

36.

Reproducible Research Practices and Transparency across the Biomedical Literature.

Iqbal SA, Wallach JD, Khoury MJ, Schully SD, Ioannidis JP.

PLoS Biol. 2016 Jan 4;14(1):e1002333. doi: 10.1371/journal.pbio.1002333. eCollection 2016 Jan.

37.

What is translational genomics? An expanded research agenda for improving individual and population health.

Schully SD, Khoury MJ.

Appl Transl Genom. 2014 Dec;3(4):82-83. No abstract available.

38.

Clinical utility of genetic and genomic services: context matters.

Dotson WD, Bowen MS, Kolor K, Khoury MJ.

Genet Med. 2016 Jul;18(7):672-4. doi: 10.1038/gim.2015.153. Epub 2015 Dec 10. No abstract available.

39.

Genomics in Public Health: Perspective from the Office of Public Health Genomics at the Centers for Disease Control and Prevention (CDC).

Green RF, Dotson WD, Bowen S, Kolor K, Khoury MJ.

Healthcare (Basel). 2015;3(3):830-7. Epub 2015 Sep 15.

40.

Planning for the Future of Epidemiology in the Era of Big Data and Precision Medicine.

Khoury MJ.

Am J Epidemiol. 2015 Dec 15;182(12):977-9. doi: 10.1093/aje/kwv228. Epub 2015 Dec 1. Review.

41.

Precision Public Health for the Era of Precision Medicine.

Khoury MJ, Iademarco MF, Riley WT.

Am J Prev Med. 2016 Mar;50(3):398-401. doi: 10.1016/j.amepre.2015.08.031. Epub 2015 Nov 4. Review. No abstract available.

42.

Targeted Cancer Screening in Average-Risk Individuals.

Marcus PM, Freedman AN, Khoury MJ.

Am J Prev Med. 2015 Nov;49(5):765-771. doi: 10.1016/j.amepre.2015.04.030. Epub 2015 Jul 10. Review.

43.

A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit.

Khoury MJ, Evans JP.

JAMA. 2015 Jun 2;313(21):2117-8. doi: 10.1001/jama.2015.3382. No abstract available.

44.

Charting a future for epidemiologic training.

Brownson RC, Samet JM, Chavez GF, Davies MM, Galea S, Hiatt RA, Hornung CA, Khoury MJ, Koo D, Mays VM, Remington P, Yarber L.

Ann Epidemiol. 2015 Jun;25(6):458-65. doi: 10.1016/j.annepidem.2015.03.002. Epub 2015 Mar 14.

45.

Can targeted genetic testing offer useful health information to adoptees?

May T, Strong KA, Khoury MJ, Evans JP.

Genet Med. 2015 Jul;17(7):533-5. doi: 10.1038/gim.2015.58. Epub 2015 Apr 23. No abstract available.

46.

Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.

Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD.

Am J Epidemiol. 2015 Apr 1;181(7):451-8. doi: 10.1093/aje/kwu479. Epub 2015 Mar 11. Review.

47.

Lam et al. respond to "Driving for further evolution".

Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD.

Am J Epidemiol. 2015 Apr 1;181(7):463. doi: 10.1093/aje/kwu478. Epub 2015 Mar 11. No abstract available.

PMID:
25767264
48.

Opportunities for translational epidemiology: the important role of observational studies to advance precision oncology.

Marrone M, Schilsky RL, Liu G, Khoury MJ, Freedman AN.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):484-9. doi: 10.1158/1055-9965.EPI-14-1086.

49.

The authors reply.

Spitz MR, Lam TK, Schully SD, Khoury MJ.

Am J Epidemiol. 2015 Mar 1;181(5):361. doi: 10.1093/aje/kwv019. Epub 2015 Feb 18. No abstract available.

50.

Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF.

J Natl Cancer Inst. 2015 Feb 16;107(4). pii: djv012. doi: 10.1093/jnci/djv012. Print 2015 Apr.

Supplemental Content

Loading ...
Support Center